Aspergillosis

  1. Denning DW.  Invasive aspergillosis.  Clin Infect Dis 1998;26:781-805.
  2. Douglas AP, Smibert OC, Bajel A, et al.  Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021.  Internal Med J 2021;51:143-76.
  3. Izumikawa K, Takazono T, Kohno S.  Chronic aspergillus infections of the respiratory tract:  diagnosis, management and antifungal resistance.  Curr Opin Infect Dis 2010;28:584-9.
  4. Johnson MD, MacDougall C, Ostrosky-Zeichner L, et al.  Combination antifungal therapy.  Antimicrob Agents Chemother 2004;48:693-715.
  5. Marr KA, Boeckh M, Carter RA, et al.  Combination antifungal therapy for invasive aspergillosis.  Clin Infect Dis 2004;39:797-802.
  6. Patterson TF, Thompson III GR, Denning DW, et al.  Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases
    Society of America.  Clin Infect Dis 2016:1-60.
  7. Schwartz S, Ruhnke M, Ribaud P, et al.  Improved outcome in central nervous system aspergillosis, using voriconazole treatment.  Blood 2005;106:2641-5.
  8. Segal BH.  Aspergillosis.  N Engl J Med 2009;360:1870-84.
  9. Segal BH, Walsh TJ.  Current approaches to diagnosis and treatment of invasive aspergillosis.  Am J Respir Crit Care Med 2006;173:707-17.
  10. Serris A, Rautemaa-Richardson R, Laranjinha J, et al.  European study of cerebral aspergillosis treated with isavuconazole: an EFISG study.  Clin Infect Dis 2024:1-16. DOI: 10.1093/cid/ciae371 
  11. Stevens DA, Kan VL, Judson MA, et al.  Practice guidelines for diseases caused by Aspergillus.  Clin Infect Dis 2000;30:696-709.
  12. Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.  Clin Microbiol Infect 2018;24:1-38.
  13. Walsh TJ, Anaissie EJ, Denning DW, et al.  Treatment of aspergillosis:  clinical practice guidelines of the Infectious Diseases Society of America.  Clin Infect Dis 2008;46:327-60.